Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Return on Sales [ROS] (2010 - 2024)

Updated

Ernexa Therapeutics (ERNA) recorded Return on Sales [ROS] of -14194.74% in Q4 2024, down 2429.43 percentage points from -11765.31% a year earlier and down 13730.88 percentage points from the prior quarter.

Analysis

Ernexa Therapeutics (ERNA) Return on Sales [ROS] (2010 - 2024) Analysis & Trends

For FY2024, Ernexa Therapeutics reported Return on Sales [ROS] of -2612.33%, up 18522.67 percentage points from FY2023.

  • Annual Return on Sales [ROS] has a five-year change of -2603.44 percentage points (FY2019 to FY2024).
  • Across earlier years, Return on Sales [ROS] came in at -21135.00% in FY2023 and -124.97% in FY2020 (-116.07 pp).
  • The Q4 2024 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q2 2010.
  • On a year-over-year basis, Return on Sales [ROS] rose in 1 of the last five quarters, with an average year-over-year change of -4448.39 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 10330.26 percentage points in Q3 2024, against a drop of 10512.78 percentage points in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -463.86% (Q3 2024), -10491.49% (Q2 2024) and -12312.77% (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Ernexa Therapeutics 3.46 Mn 3.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -14,194.74%
Sep 30, 2024 -463.86%
Jun 30, 2024 -10,491.49%
Mar 31, 2024 -12,312.77%
Dec 31, 2023 -11,765.31%
Sep 30, 2023 -10,794.12%
Mar 31, 2023 -2,743.57%
Dec 31, 2022 -1,252.53%
Sep 30, 2022 -733.29%
Dec 31, 2020 -187.80%
Sep 30, 2020 -135.92%
Mar 31, 2020 -42.38%
Dec 31, 2019 -23.74%
Sep 30, 2019 -6.90%
Jun 30, 2019 -0.04%
Mar 31, 2019 -4.49%
Dec 31, 2018 2.92%
Sep 30, 2018 6.16%
Jun 30, 2018 -0.48%
Mar 31, 2018 -5.43%
API Access

Ernexa Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ERNA&period=max&api_key=YOUR_API_KEY